Samsung Is Testing Galaxy Watch 8 To Prevent Muscle Loss On GLP-1s Like Ozempic

Samsung and Massachusetts General Hospital are launching a study to test whether Galaxy Watch 8 data can help GLP-1 users avoid muscle loss.

The trial will enroll 100 adults starting GLP-1 therapy and compare a watch-based program with standard care.

Researchers will use wearable biometric data and personalized exercise guidance to monitor risk and support healthier body composition.

Body composition changes will be measured with DXA scans, and the study could show how smartwatches help clinicians manage GLP-1 side effects.